TREA

88631158 - IDERA

Follow

Information

  • Trademark
  • 88631158
  • Serial Number
    88631158
  • Registration Number
    6223085
  • Filing Date
    September 25, 2019
    5 years ago
  • Registration Date
    December 15, 2020
    4 years ago
  • Transaction Date
    December 15, 2020
    4 years ago
  • Status Date
    December 15, 2020
    4 years ago
  • Published for Opposition Date
    February 04, 2020
    5 years ago
  • Location Date
    November 06, 2020
    4 years ago
  • First Use Anywhere Date
    June 01, 2008
    16 years ago
  • First Use In Commerce Date
    June 01, 2008
    16 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DUBRAY, KATHERINE M
  • Attorney Docket Number
    105968-0012
    Attorney Name
    Rebecca E. McDougall
    Law Office Assigned Location Code
    M90
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
IDERA
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of the word "IDERA" and a design element. The design element is positioned above and to the left of the word "IDERA" and consists of six circles around a common center. Four of those circles are connected to matching circles such that they resemble cells that are in the act of splitting. One of the two other circles forms the dot in the letter "I" in "IDERA".
  • GS0051: Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
Case File Event Statements
  • 12/15/2020 - 4 years ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/7/2020 - 4 years ago
    15 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 11/6/2020 - 4 years ago
    14 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 10/15/2020 - 4 years ago
    13 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 9/29/2020 - 4 years ago
    12 - USE AMENDMENT FILED Type: IUAF
  • 10/15/2020 - 4 years ago
    11 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 9/29/2020 - 4 years ago
    10 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 3/31/2020 - 4 years ago
    9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/4/2020 - 5 years ago
    8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/4/2020 - 5 years ago
    7 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/15/2020 - 5 years ago
    6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/27/2019 - 5 years ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/27/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/2/2019 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/1/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/28/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP